Cartier Victoire, Boursier Jérôme, Lebigot Jérôme, Oberti Frédéric, Fouchard-Hubert Isabelle, Aubé Christophe
Department of Radiology, University Hospital, Angers, France.
Department of Hepato-Gastroenterology, University Hospital, Angers, France.
J Gastroenterol Hepatol. 2016 Mar;31(3):654-60. doi: 10.1111/jgh.13179.
Thermo-ablation by radiofrequency is recognized as a curative treatment for early-stage hepatocellular carcinoma. However, local recurrence may occur because of incomplete peripheral tumor destruction. Multipolar radiofrequency has been developed to increase the size of the maximal ablation zone. We aimed to compare the efficacy of monopolar and multipolar radiofrequency for the treatment of hepatocellular carcinoma and determine factors predicting failure.
A total of 171 consecutive patients with 214 hepatocellular carcinomas were retrospectively included. One hundred fifty-eight tumors were treated with an expandable monopolar electrode and 56 with a multipolar technique using several linear bipolar electrodes. Imaging studies at 6 weeks after treatment, then every 3 months, assessed local effectiveness. Radiofrequency failure was defined as persistent residual tumor after two sessions (primary radiofrequency failure) or local tumor recurrence during follow-up. This study received institutional review board approval (number 2014/77).
Imaging showed complete tumor ablation in 207 of 214 lesions after the first session of radiofrequency. After a second session, only two cases of residual viable tumor were observed. During follow-up, there were 46 local tumor recurrences. Thus, radiofrequency failure occurred in 48/214 (22.4%) cases. By multivariate analysis, technique (P < 0.001) and tumor size (P = 0.023) were independent predictors of radiofrequency failure. Failure rate was lower with the multipolar technique for tumors < 25 mm (P = 0.023) and for tumors between 25 and 45 mm (P = 0.082). There was no difference for tumors ≥ 45 mm (P = 0.552).
Compared to monopolar radiofrequency, multipolar radiofrequency improves tumor ablation with a subsequent lower rate of local tumor recurrence.
射频热消融被认为是早期肝细胞癌的一种治愈性治疗方法。然而,由于肿瘤周边消融不完全,可能会发生局部复发。已开发出多极射频以增大最大消融区的大小。我们旨在比较单极和多极射频治疗肝细胞癌的疗效,并确定预测治疗失败的因素。
回顾性纳入了连续171例患有214个肝细胞癌的患者。158个肿瘤采用可扩张单极电极治疗,56个肿瘤采用多极技术(使用多个线性双极电极)治疗。治疗后6周进行影像学检查,然后每3个月进行一次影像学检查,以评估局部疗效。射频治疗失败定义为经过两次治疗后仍有持续性残留肿瘤(原发性射频治疗失败)或随访期间出现局部肿瘤复发。本研究获得了机构审查委员会的批准(编号2014/77)。
影像学显示,在首次射频治疗后,214个病灶中有207个实现了肿瘤完全消融。在第二次治疗后,仅观察到2例残留存活肿瘤病例。在随访期间,有46例发生局部肿瘤复发。因此,214例中有48例(22.4%)出现射频治疗失败。多因素分析显示,技术(P<0.001)和肿瘤大小(P=0.023)是射频治疗失败的独立预测因素。对于直径<25mm的肿瘤(P=0.023)和直径在25至45mm之间的肿瘤(P=0.082),多极技术的失败率较低。对于直径≥45mm的肿瘤,两者无差异(P=0.552)。
与单极射频相比,多极射频可改善肿瘤消融效果,并降低随后的局部肿瘤复发率。